SamanTree Medical wins PERL 2018 edition

4th May 2018

SamanTree Medical wins 2018 edition of the Prix Entreprendre Région Lausanne (PERL).

The prestigious PERL competition rewards SamanTree Medical for its Histolog™ Scanner, a breakthrough imaging modality offering a direct support during cancer surgery to improve patient quality of life by decreasing rates of reoperation.

Every year since 2003, the PERL trophy rewards with 50’000 Swiss francs the most innovative project from the 27 cities of Région Lausanne. The laureate is selected by a jury from academia, business and press after rigorous assessment of its economic potential and viability, as well as its impact for the region.

Congratulations to the other finalists Darix Sàrl, Nagi Bioscience SA, Swiss Motion Technologies SA and TWIICE SA.

Click here to know more about the PERL (in French).

Etienne Shaffer (CTO) and Bastien Rachet (CEO). ©ARC/Jean-Bernard Sieber

Previous
Previous

The Histolog™ Scanner presented at the ParisBreast Rendez-Vous 2018

Next
Next

Breast cancer study results presented at EBCC-11